Answers are grounded in this paper and cite their sources.
As of June 30, 2022, there have been 87,298,343 cases of coronavirus disease 2019 reported in the United States, of which approximately 17.4% occurred in children 0-17 years old (1).So far in 2022, individuals 0-19 years old have accounted for 23.6% of cases, a considerable increase, from 14.4%, throughout 2020 (Figure 1).The increasing case burden in children corresponds with differential vaccine access and uptake compared with adults, of whom the vast majority received an mRNA COVID-19 vaccine (Pfizer-BioN-Tech or Moderna; ref. 1).The first Emergency Use Authorization (EUA) for Pfizer-Bi-oNTech was issued on December 11, 2020, by the FDA, and it was the only available option for individuals 16 years and older (Figure 1 and ref. 2).It was not until May 10, 2021, almost 5 months later, that the FDA expanded the EUA for Pfizer-BioNTech to include adolescents 12-15 years old (Figure 1 and ref. 3).
No takes yet. Share an insight, caveat, or question.
Amarin et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: